We thus hypothesized that PARP1 might be integral to the establishment of G2DHE into an oncogenic super-enhancer on the rearranged 3q allele and necessary to maintain EVI1 expression in inv(3)/t(3;3) AML. Here, MECOM is linked to acute myeloid leukemia.